Tyro3 deletion is protective in experimental autoimmune encephalomyelitis

Area of Science:

• Neuroimmunology
• Molecular Biology
• Demyelinating Diseases

Background:

• Multiple sclerosis (MS) involves complex interactions between the adaptive and innate immune systems and the central nervous system (CNS).
• Potential MS therapies may have conflicting effects across different tissues, necessitating system-wide effect exploration.
• Gas6, a circulating protein and ligand for TAM receptors, is a candidate for promoting remyelination in MS.

Purpose of the Study:

• To investigate the system-wide effects of Gas6 and its receptor Tyro3 in experimental autoimmune encephalomyelitis (EAE), a model for MS.
• To elucidate the role of TAM receptor signaling in inflammatory demyelination.

Main Methods:

• Global genetic deletion of Gas6 or the Tyro3 receptor in mice.
• Induction of experimental autoimmune encephalomyelitis (EAE) to model MS.
• Analysis of disease severity and cytokine expression (IL-4, IL-17A) in lymph node and spinal cord tissues.

Main Results:

• Global genetic deletion of Gas6 or Tyro3 resulted in reduced EAE disease severity in mice.
• Tyro3 knockout (KO) mice exhibited increased IL-4 and IL-17A expression in lymph nodes.
• Conversely, Tyro3 KO mice showed decreased IL-4 and IL-17A expression in spinal cord tissues.

Conclusions:

• Gas6 and TAM receptor signaling play a multifaceted role in inflammatory demyelination.
• Modulating Gas6-TAM interactions may offer therapeutic strategies for MS by influencing immune responses and CNS pathology.